Proposals for Panels, Mini-Panels, and Study Groups
The College will begin accepting Panel, Mini-Panel, and Study Group proposals for consideration for the January 2026 Annual Meeting in April 2025 . The final deadline to submit is June 12, 2025 .
*Continuing in 2026, duration of panels and study groups will be 2 hours, and mini-panels will be 50 minutes.
Panel Guidelines
Mini-Panel Guidelines
Study Group Guidelines
January 2026 Call for Proposals
DEADLINES:
Panels, Mini-Panels & Study Groups
- Chairs must create the submission and invite presenters no later than Tuesday, May 27, 2025.
- Presenters must submit individual abstracts & disclosures no later than Tuesday, June 10, 2025.
- Study group presenters must submit disclosures no later than Tuesday, June 10, 2025.
- Chairs must review, finalize and submit proposed sessions no later than Thursday, June 12, 2025.
All Submission Deadlines are 5:00 PM Central Time. Notifications will be emailed in mid-August 2025.
9 Common Reasons Why an Abstract is Not Accepted:
-
- Insufficient data and/or statistical analyses.
- To address scientific rigor, each data presentation should report N, and ideally an effect size and power calculation. Preliminary or hypothesis-generating studies are of interest and would be expected to have a smaller ‘N’, but should be explicitly labeled as such.
- The session is not sufficiently cohesive.
- The session is not sufficiently innovative.
- The session does not include sufficient novel/new data.
- The theme of the session is over-represented in current submissions for this year.
- Similar sessions have been presented in recent ACNP meetings.
- The abstract(s) is not informative enough.
- The panel/mini panel speaker composition does not include a broad slate of participants and/or early career scientist/clinician representation.
- Speakers are not from diverse institutions.
- Insufficient data and/or statistical analyses.
Poster Abstracts
The College will begin accepting poster abstracts for consideration once registration opens this summer. The final deadline to submit a poster is August 28, 2025 at 5:00pm Central time. All attendees must be registered in order to submit a poster abstract submission. The deadline will not be extended under any circumstances.
January 2026 Poster Guidelines will be posted soon.
Please Note: Maximum Poster Size is 45″ X 45″.
Encore Presentations: Original data is preferred, if the abstract is accepted for presentation but has been previously published, it will not be published in ACNP’s journal Neuropsychopharmacology. However, encore presentations can be submitted. ACNP does not accept late-breaking abstracts for the annual meeting.
Notifications: All poster abstract submissions are reviewed by the Program Committee. Notifications of acceptance or otherwise will be emailed to the presenter in late September / early October.
If you are not a member of ACNP, please review the Annual Meeting FAQs for additional information.
Promising Targets – *NEW in 2024*
January 2026 Promising Targets information will be posted soon.
Submissions will open in October 2025. The deadline for submissions is October 27, 2025 at 5:00pm Central.
To showcase and promote discussion around the most recent and exciting clinical and translational neuropharmacology at ACNP 2024, this year we are holding a new call for Promising Targets Abstracts focused on new results from clinical trials and novel pharmacological targets. Abstracts considered ‘Promising Targets’ are those that contain exciting and important findings that were not available prior to the ACNP 2024 August 8th General Abstract deadline earlier this year. This Promising Targets deadline is not an extension of the General Abstract submission deadline.
This special session will highlight six (6) speakers, each with a ten (10) minute talk plus ten (10) minute discussion.
All Promising Target Abstracts must:
- Include data that could not be analyzed before the ACNP General Abstract deadline, due to unavailability of the data.
- Present significant, ground-breaking, and innovative results.
- Address a novel clinical, translational, or methodological question.
- Apply to clinical/translational neuropharmacology.
- Describe original, previously unpublished work at the time of presentation.
- Obtain management approval prior to submitting the abstract if management approval is required from your company/institution. If the abstract is withdrawn after acceptance for reasons such as lack of management approval, you will be barred from submitting an abstract to ACNP the following year.
2024 Promising Targets Guidelines
Promising Targets Promotional Flyer
The College is accepting Promising Targets submissions for consideration at the 2024 Annual Meeting starting on September 23, 2024. The deadline to submit is October 7, 2024. The deadline will not be extended under any circumstances. Anyone can submit (except for selected Data Blitz and Hot Topics presenters). A person does not have to already have an invitation to the meeting to submit. A person does not need an ACNP member to chair their submission. If their presentation is accepted, they will receive an invitation to the meeting if they do not already have one.
Notifications: All abstract submissions are reviewed by the Program Committee. Notifications of acceptance or otherwise will be emailed to the presenter in late October 2024.
Media Embargo Policy
Any press release or public promotion by a presenter, the presenter’s employer, or any other outside person or entity about a presentation scheduled for the ACNP Annual Meeting must be embargoed (not released) until the time and date of the presentation. Additionally, ACNP should not be mentioned or referenced regarding the data or presentation until the first date of the Annual Meeting. If referenced at that point, it should be clear that the release/posting is not sanctioned by ACNP. This includes any detail of the abstract and the data from the presentation.
Abstract Submission Copyright
All materials submitted for presentation at the Annual Meeting will be published in Neuropsychopharmacology and should be original and not previously published. Following publication authors may reuse their work with the sole requirements of full citation and link to the original publication online.